Spondyloepiphyseal Dysplasia Tarda with Progressive Arthropathy with Delayed Diagnosis

Spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA) is a rare autosomal recessive hereditary skeletal disease, and mutations in WISP3 are responsible for its onset. WISP3 is essential for maintaining cartilage integrity mainly by regulating the expression of collagen II, and mutations of WISP3 linked to SEDT-PA can compromise this function and lead to cartilage loss, which is frequently misdiagnosed as juvenile idiopathic arthritis. It is characterized by arthralgia, joint contractures, bony swelling of metacarpophalangeal and interphalangeal joints and platyspondyly. Clinical and laboratory signs of joint inflammation such as synovitis, a high erythrocyte sedimentation rate and an elevated C-reactive protein level are usually absent. Although the disease begins early in life (usually between 3 and 8 years of age), the diagnosis may be delayed. In the present case report, we describe a female patient diagnosed with SEDT-PA at the age of 40 years, although she had been exhibiting the typical radiological and clinical features of the disease since the age of 8 years. Genetic disorders like SEDT-PA may also have rheumatological involvement, and thus should be kept in mind in the differential diagnosis of inflammatory joint diseases.

Anahtar Kelimeler:

Spondyloepiphyseal dysplasia, pseudorheumatoid arthropathy, progressive arthropathy, osteochondrodysplasias

Spondyloepiphyseal Dysplasia Tarda with Progressive Arthropathy with Delayed Diagnosis

Keywords:

Spondyloepiphyseal dysplasia, pseudorheumatoid arthropathy, progressive arthropathy, osteochondrodysplasias,

PDF

___

1. Kaptanoglu E, Percin F, Percin S, Törel-Ergür A. Spondyloepiphyseal dysplasia tarda with progressive arthropathy. Turk J Pediatr 2004; 46(4): 380-3.
2. Online Mendelian Inheritance in Man, Omim (TM) Johns Hopkins University, Baltimore, MD 1999: MIM Number 208230: World Wide Web URL. Available from: http://www.ncbi.nlm.nih. gov/omim/
3. Bennani L, Amine B, Ichchou L, Lazrak N, Hajjaj-Hassouni N. Progressive pseudorheumatoid dysplasia: three cases in one family. Joint Bone Spine 2007; 74: 393-5.
4. Kaya A, Ozgocmen S, Kiris A, Ciftci I. Clinical and radiological diagnosis of progressive pseudorheumatoid dysplasia in two sisters with severe polyarthropathy. Clin Rheumatol 2005; 24(5): 560-4.
5. Yang Y, Liao E. Mutant WISP3 triggers the phenotype shift of articular chondrocytes by promoting sensitivity to IGF-1 hypothesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA). Med Hypotheses 2007; 68: 1406-10.
6. Cui R, Huang J, Yi L, Xie H, Zhou HD, Yuan LQ et al. WISP3 suppresses insulin-like growth factor signaling in human chondrocytes. Mol Cell Endocrinol 2007; 279: 1-8.
7. Davis L, Chen Y, Sen M. WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem Biophys Res Commun 2006; 342(1): 259-65.
8. Cefle A, Cefle K, Tunacı M, Ozturk S, Palanduz S. A case of progressive pseudorheumatoid arthropathy of 'childhood' with the diagnosis delayed to the fifth decade. Int J Clin Pract 2006; 60(10): 1306-9.
9. Teebi AS, Awadi SA. Spondyloepiphyseal dysplasia tarda with progressive arthropathy: a rare disorder frequently diagnosed among Arabs. J Med Genet 1986; 23: 189-91.
10. Spranger J, Albert C, Schilling F, Bartsocas C, Stöss H. Progressive pseudorheumatoid arthritis of childhood (PPAC). A hereditary disorder simulating rheumatoid arthritis. Eur J Pediatr 1983; 140: 34-40.
11. Alkhateeb A, al-Alami J, Leal SM, el-Shanti H. Fine mapping of progressive pseudorheumatoid dysplasia: a tool for heterozygote identification. Genet Test 1999; 4: 329-33.
12. Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 1999; 23: 94-8.
13. Balci S, Aypar E, Kasapcopur O, Tüysüz B, Arisoy N. An elevenyear-old female Turkish patient with progressive pseudorheumatoid dysplasia mimicking juvenile idiopathic arthritis. Clin Exp Rheumatol 2001; 19: 759.
14. Arslanoglu S, Hizarcioglu M, Genel F. Spondyloepiphyseal dysplasia tarda with progressive arthropathy: an important form of osteodysplasia in the differential diagnosis of juvenile rheumatoid arthritis. Pediatr Int 2000; 42: 561-3.
15. Kocyigit H, Arkun R, Ozkinay F, Cogulu O, Hizli N, Memis A. Spondyloepiphyseal dysplasia tarda with progressive arthropathy. Clin Rheumatol 2000; 19: 238-41.
16. Fiedler J, Le Merrer M, Mortier G, Heuertz S, Faivre L, Brenner RE. X-linked spondyloepiphyseal dysplasia tarda: novel and recurrent mutations in 13 European families. Hum Mutat 2004; Mutation in Brief 725, Online.
17. Ehl S, Uhl M, Berner R, Bonafe L, Superti-Furga A, Kirchhoff A. Clinical, radiographic, and genetic diagnosis of progressive pseudorheumatoid dysplasia in a patient with severe polyarthropathy. Rheumatol Int 2004; 24: 53-6.